June 2026
The global pulmonary embolism market size is estimated to hit around USD 2.70 billion by 2035 increasing from USD 6.04 billion in 2025, with a CAGR of 8.38%.
August 2026
The pulmonary alveolar proteinosis (PAP) drugs market reached USD 859.05Â million in 2026, with key pulmonary alveolar proteinosis (PAP) drugs market companies including Savara, Inc., Partner Therapeutics, Inc., Nobelpharma Co., Ltd. Amgen Inc
August 2026
The global pulmonary drug delivery systems market size is projected to hit around USD 91.51 billion by 2035 from USD 58.33 billion in 2025, with a CAGR of 4.61%.
March 2026
The global pulmonary arterial hypertension market size is expected to increase to USD 13.50 billion by 2034 from USD 8.48 billion in 2025 with a CAGR of 5.30%.
December 2025
The chronic obstructive pulmonary disease treatment market size is expected to hit around USD 33.03 billion by 2035 from USD 21.04 billion in 2025 at a CAGR of 5.14%.